Hong Kong Pharmaceuticals & Biotech Top Dividend Payers

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.3b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$6.1b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

Essex Bio-Technology

Market Cap: HK$1.8b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Tong Ren Tang Technologies

Market Cap: HK$4.9b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

SSY Group

Market Cap: HK$6.7b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$96.2b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

China Shineway Pharmaceutical Group

Market Cap: HK$7.3b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.7b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.